Absci Corporation (ABSI)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Sean McClain
|
Founder, CEO, President & Director | 1.08M | -- | 1990 |
|
Dr. Zachariah Jonasson Ph.D.
|
Chief Business Officer & CFO | 816.51k | -- | 1973 |
|
Mr. Todd Bedrick CPA
|
Senior VP & Chief Accounting Officer | -- | -- | -- |
|
Mr. Alexander Khan CPA
|
CVP of Finance & Head of Investor Relations | -- | -- | -- |
|
Ms. Shelby Walker J.D.
|
Chief Legal Officer | -- | -- | 1975 |
|
Ms. Jeanne Schreuder M.B.A., SPHR
|
Senior Vice President of People & Experience | -- | -- | -- |
|
Mr. Wen Sha
|
Chief of Staff | -- | -- | -- |
|
Dr. Christine Lemke D.V.M., M.B.A., Ph.D.
|
Senior Vice President of Portfolio & Growth Strategy | -- | -- | -- |
|
Dr. Ransi Somaratne FACC, M.B.A., M.D.
|
Chief Medical Officer | -- | -- | 1966 |
|
Dr. Moetaz B. Albizem M.D.
|
Senior Vice President of Clinical Operations | -- | -- | -- |
Absci Corporation
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 140
Description
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Corporate Governance
Upcoming Events
November 12, 2026 at 12:30 PM UTC
Absci Corporation Earnings Date
